Scholars@Duke
Journal cover image

Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.

Publication ,  Journal Article
Lee, I; Sanders, D
Published in: Muscle Nerve
October 2021
Published version (DOI) Link to item

Duke Scholars

Donald Benjamin Sanders
Author Donald Benjamin Sanders Neurology, Neuromuscular Disease
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Muscle Nerve

DOI

10.1002/mus.27381

EISSN

1097-4598

Publication Date

October 2021

Volume

64

Issue

4

Start / End Page

385 / 387

Location

United States

Related Subject Headings

  • Receptors, Cholinergic
  • Neurology & Neurosurgery
  • Myasthenia Gravis
  • Humans
  • Biomarkers
  • Autoantibodies
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, I., & Sanders, D. (2021). Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis. Muscle Nerve, 64(4), 385–387. https://doi.org/10.1002/mus.27381
Lee, Ikjae, and Donald Sanders. “Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.” Muscle Nerve 64, no. 4 (October 2021): 385–87. https://doi.org/10.1002/mus.27381.
Lee, Ikjae, and Donald Sanders. “Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.” Muscle Nerve, vol. 64, no. 4, Oct. 2021, pp. 385–87. Pubmed, doi:10.1002/mus.27381.
Journal cover image

Published In

Muscle Nerve

DOI

10.1002/mus.27381

EISSN

1097-4598

Publication Date

October 2021

Volume

64

Issue

4

Start / End Page

385 / 387

Location

United States

Related Subject Headings

  • Receptors, Cholinergic
  • Neurology & Neurosurgery
  • Myasthenia Gravis
  • Humans
  • Biomarkers
  • Autoantibodies
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences